Mechanisms of disease: involvement of the urothelium in bladder dysfunction
LA Birder, WC De Groat - Nature clinical practice Urology, 2007 - nature.com
Although the urinary bladder urothelium has classically been thought of as a passive barrier
to ions and solutes, a number of novel properties have been recently attributed to urothelial …
to ions and solutes, a number of novel properties have been recently attributed to urothelial …
Urothelial signaling
LA Birder - Autonomic Neuroscience, 2010 - Elsevier
Beyond serving as a simple barrier, there is growing evidence that the urinary bladder
urothelium exhibits specialized sensory properties and play a key role in the detection and …
urothelium exhibits specialized sensory properties and play a key role in the detection and …
Urothelial signaling
LA Birder - Urinary Tract, 2011 - Springer
The urinary bladder “mucosa” or innermost portion of the bladder is composed of transitional
epithelium, basement membrane, and the lamina propria. This chapter reviews the …
epithelium, basement membrane, and the lamina propria. This chapter reviews the …
The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder
Human bladder contraction mainly depends on Ca2+ influx via L-type voltage-gated Ca2+
channels and on RhoA/Rho kinase contractile signaling, which is upregulated in overactive …
channels and on RhoA/Rho kinase contractile signaling, which is upregulated in overactive …
[HTML][HTML] Emerging molecular mechanisms and genetic targets for developing novel therapeutic strategies for treating bladder diseases
R Zoqlam, S Lazauskaite, S Glickman… - European Journal of …, 2022 - Elsevier
Bladder diseases affect millions of patients worldwide and compromise their quality of life
with a substantial economic impact. The not fully understood aetiologies of bladder diseases …
with a substantial economic impact. The not fully understood aetiologies of bladder diseases …
Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder
E Esin, A Ergen, M Cankurtaran, BB Yavuz… - Aging & mental …, 2015 - Taylor & Francis
Objectives: Incidences of overactive bladder (OAB) and cognitive dysfunction increase with
aging. Treatment of OAB with antimuscarinic agents may result in cognitive decline …
aging. Treatment of OAB with antimuscarinic agents may result in cognitive decline …
[PDF][PDF] Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder
EM Pelletier, V Vats, JQ Clemens - Am J Manag Care, 2009 - ajmc.s3.amazonaws.com
Objective: To evaluate adherence with overactive bladder (OAB) pharmacotherapy and
compare costs between patients receiving pharmacotherapy versus nonpharmacologic …
compare costs between patients receiving pharmacotherapy versus nonpharmacologic …
Compositions for the treatment of overactive bladder
M Paborji - US Patent 7,678,821, 2010 - Google Patents
Disclosed herein are pharmaceutical compositions compris ing combinations oftolterodine,
an antimuscarinic agent, and pilocarpine, a compound that causes stimulation of salivary …
an antimuscarinic agent, and pilocarpine, a compound that causes stimulation of salivary …
[HTML][HTML] Non-Pharmacological Management of Urge Urinary Incontinence in Women between 40 and 65 Years Old: A Systematic Review
S Trapani, G Villa, A Poliani, S Gnecchi, D Rosa… - Nursing Reports, 2024 - mdpi.com
Background: Urinary incontinence (UI) has been identified as a World Health Organization
health priority. In particular, urge UI (UUI) refers to urine leakage associated with a sudden …
health priority. In particular, urge UI (UUI) refers to urine leakage associated with a sudden …
Therapy for the treatment of disease
M Paborji - US Patent 7,666,894, 2010 - Google Patents
Disclosed herein are pharmaceutical compositions compris ing oxybutynin, or a free base
thereof or a pharmaceutically acceptable salt thereof, and pilocarpine, or a free base thereof …
thereof or a pharmaceutically acceptable salt thereof, and pilocarpine, or a free base thereof …